Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Evaluation of the Safety of Lipiodol??? Embolization in Symptomatic Digital Osteoarthritis Refractory to Conventional Treatment: a Pilot Study of 15 Patients

Next Previous
Trial Profile

Evaluation of the Safety of Lipiodol??? Embolization in Symptomatic Digital Osteoarthritis Refractory to Conventional Treatment: a Pilot Study of 15 Patients

Status: Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 06 Feb 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ethiodized oil (Primary)
  • Indications Osteoarthritis
  • Focus Adverse reactions
  • Acronyms EMBARDI

Most Recent Events

  • 03 Feb 2025 Planned End Date changed from 15 Apr 2028 to 15 Jul 2028.
  • 03 Feb 2025 Planned primary completion date changed from 15 Apr 2028 to 15 Jul 2028.
  • 11 Dec 2024 Planned initiation date (estimated date for recruitment of the first subject) changed from 15 Nov 2024 to 15 Dec 2024.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top